Erratum: Human T-cell lymphotropic virus type 1 infection of CD34 + hematopoietic progenitor cells induces cell cycle arrest by modulation of p21cip1/waf1 and survivin (Stem Cells (2008) DOI:10.1634/stemcells.2008-0353));Human T-cell lymphotropic virus type 1 infection of CD34+ hematopoietic progenitor cells induces cell cycle arrest by modulation of p21cip1/waf1 and survivin

Stem Cells

Volumn 26, Issue 12, 2008, Pages 3047-3058

  Banerjee, Prabal ^a   Sieburg, Michelle ^a   Samuelson, Elizabeth ^a   Feuer, Gerold ^a,b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Cell cycle heterogeneity; Lentiviral vectors; Leukemia; Stem progenitor cell; Viral persistence

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; SURVIVIN;

ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LEUKEMOGENESIS; NONHUMAN; PROTEIN EXPRESSION; T CELL LEUKEMIA; VIRUS INFECTION;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 58049208062     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1527     Document Type: Erratum

References (89)

1. Sindre H, Tjoonnfjord GE, Rollag H et al. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 1996;88:4526-4533.
2. MacKintosh FR, Adlish J, Hall SW et al. Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol 1993;21:243-250.
3. Goodrum F, Jordan CT, Terhune SS et al. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 2004;104:687-695.
4. Isomura H, Yoshida M, Namba H et al. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro. J Gen Virol 2000;81:663-673.
5. Isomura H, Yamada M, Yoshida M et al. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 1997;52:406-412.
6. Manchester M, Smith KA, Eto DS et al. Targeting and hematopoietic suppression of human CD34+ cells by measles virus. J Virol 2002;76:6636-6642.
7. Finstad SL, Rosenberg N, Levy LS. Diminished potential for B-lymphoid differentiation after MuLV infection in vivo and in EML hematopoietic progenitor cells. J Virol 2007;81:7274-7279.
8. Wu W, Vieira J, Fiore N et al. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: Persistence of infection during hematopoiesis in vitro and in vivo. Blood 2006;108:141-151.
9. Furukawa Y. Cell cycle control genes and hematopoietic cell differentiation. Leuk Lymphoma 2002;43:225-231.
10. Cheng T, Rodrigues N, Shen H et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000;287:1804-1808.
11. Cheng T, Rodrigues N, Dombkowski D et al. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med 2000;6:1235-1240.
12. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921.
13. Li F, Ackermann EJ, Bennett CF et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1999;1:461-466.
14. Li F, Ambrosini G, Chu EY et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-584.
15. Fukuda S, Pelus LM. Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle 2002;1:322-326.
16. Fukuda S, Mantel CR, Pelus LM. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood 2004;103:120-127.
17. Fukuda S, Foster RG, Porter SB et al. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002;100:2463-2471.
18. Hikita S, Hatano M, Inoue A et al. Overexpression of TIAP/m-survivin in thymocytes enhances cell proliferation. Mol Immunol 2002;39:289-298.
19. Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J 1999;344 Pt 2:305-311.
20. Suzuki A, Hayashida M, Ito T et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 2000;19:3225-3234.
21. Suzuki A, Shiraki K. Tumor cell "dead or alive": Caspase and survivin regulate cell death, cell cycle and cell survival. Histol Histopathol 2001;16:583-593.
22. Poiesz BJ, Ruscetti FW, Gazdar AF et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-7419.
23. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001;19:475-496.
24. Brauweiler A, Garrus JE, Reed JC et al. Repression of bax gene expression by the HTLV-1 Tax protein: Implications for suppression of apoptosis in virally infected cells. Virology 1997;231:135-140.
25. Jeang KT, Widen SG, Semmes OJ et al. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 1990;247:1082-1084.
26. Kibler KV, Jeang KT. CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein. J Virol 2001;75:2161-2173.
27. Lemasson I, Robert-Hebmann V, Hamaia S et al. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax. J Virol 1997;71:1975-1983.
28. Riou P, Bex F, Gazzolo L. The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors. J Biol Chem 2000;275:10551-10560.
29. Suzuki T, Narita T, Uchida-Toita M et al. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Virology 1999;259:384-391.
30. Uittenbogaard MN, Giebler HA, Reisman D et al. Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J Biol Chem 1995;270:28503-28506.
31. Tripp A, Banerjee P, Sieburg M et al. Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: Modulation of p21cip1/waf1 and p27kip1 expression. J Virol 2005;79:14069-14078.
32. Feuer G, Fraser JK, Zack JA et al. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: Maintenance of virus infection during differentiation in vitro and in vivo. J Virol 1996;70:4038-4044.
33. Tripp A, Liu Y, Sieburg M et al. Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro. J Virol 2003;77:12152-12164.
34. Banerjee P, Rochford R, Antel J et al. Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells. J Virol 2007;81:1690-1700.
35. Roy V, Miller JS, Verfaillie CM. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Exp Hematol 1997;25:387-394.
36. Kilpatrick DC, Atkinson AP, Palmer JB et al. Developmental variation in stem-cell markers from human fetal liver and umbilical cord blood leukocytes. Transfus Med 1998;8:103-109.
37. Serke S, Sauberlich S, Abe Y et al. Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: Flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays. Ann Hematol 1991;62:45-53.
38. Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 2001;98:2091-2100.
39. Gothot A, Pyatt R, McMahel J et al. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood 1997;90:4384-4393.
40. Zhao RY, Elder RT. Viral infections and cell cycle G2/M regulation. Cell Res 2005;15:143-149.
41. Zhao RY, Bukrinsky M, Elder RT. HIV-1 viral protein R (Vpr) & host cellular responses. Indian J Med Res 2005;121:270-286.
42. Andersen JL, Le Rouzic E, Planelles V. HIV-1 Vpr: Mechanisms of G2 arrest and apoptosis. Exp Mol Pathol 2008;85:2-10.
43. An DS, Wersto RP, Agricola BA et al. Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34() cells. J Virol 2000;74:1286-1295.
44. Bonaparte MI, Barker E. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 2004;104:2087-2094.
45. Marinescu VD, Kohane IS, Riva A. MAPPER: A search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005;6:79.
46. Nakata Y, Tomkowicz B, Gewirtz AM et al. Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells. Blood 2006;107:4234-4239.
47. Vella AT, McCormack JE, Linsley PS et al. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 1995;2:261-270.
48. Chintharlapalli S, Papineni S, Ramaiah SK et al. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 2007;67:2816-2823.
49. Radhakrishnan SK, Gartel AL. A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity. Cancer Res 2006;66:3264-3270.
50. Lehky TJ, Cowan EP, Lampson LA et al. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J Virol 1994;68:1854-1863.
51. Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 1997;94:5320-5325.
52. Dick JE, Bhatia M, Gan O et al. Assay of human stem cells by repopulation of NOD/SCID mice. STEM CELLS 1997;15(suppl 1):199 -203; discussion 204-197.
53. Huang S, Terstappen LW. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Blood 1994;83:1515-1526.
54. Xiao M, Dooley DC. Cellular and molecular aspects of human CD34+ CD38- precursors: Analysis of a primitive hematopoietic population. Leuk Lymphoma 2000;38:489-497.
55. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 1996;2:1329-1337.
56. Bunting KD, Hawley RG. Integrative molecular and developmental biology of adult stem cells. Biol Cell 2003;95:563-578.
57. Stier S, Cheng T, Forkert R et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 2003;102:1260-1266.
58. Zhang J, Attar E, Cohen K et al. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells. Gene Ther 2005;12:1444-1452.
59. Zhang J, Scadden DT, Crumpacker CS. Primitive hematopoietic cells resist HIV-1 infection via p21. J Clin Invest 2007;117:473-481.
60. Gurbuxani S, Xu Y, Keerthivasan G et al. Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci U S A 2005;102:11480-11485.
61. Richardson JH, Edwards AJ, Cruickshank JK et al. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990;64:5682-5687.
62. Hoffman WH, Biade S, Zilfou JT et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002;277:3247-3257.
63. Raj D, Liu T, Samadashwily G et al. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis 2008;29:194-201.
64. Mirza A, McGuirk M, Hockenberry TN et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002;21:2613-2622.
65. Civin CI. Human monomyeloid cell membrane antigens. Exp Hematol 1990;18:461-467.
66. Civin CI, Loken MR. Cell surface antigens on human marrow cells: Dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. Int J Cell Cloning 1987;5:267-288.
67. Taniguchi T, Endo H, Chikatsu N et al. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 1999;93:4167-4178.
68. Steinman R, Yaroslavskiy B, Goff JP et al. Cdk-inhibitors and exit from quiescence in primitive haematopoietic cell subsets. Br J Haematol 2004;124:358-365.
69. Walkley CR, Fero ML, Chien WM et al. Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2005;7:172-178.
70. Kehn K, Deng L, de la Fuente C et al. The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology 2004;1:6.
71. Chowdhury IH, Farhadi A, Wang XF et al. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2. Int J Cancer 2003;107:603-611.
72. Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: Possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene 1996;12:1645-1652.
73. Kuo YL, Giam CZ. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J 2006;25:1741-1752.
74. Sieburg M, Tripp A, Ma JW et al. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J Virol 2004;78:10399-10409.
75. Okada H, Bakal C, Shahinian A et al. Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med 2004;199:399-410.
76. Mori N, Yamada Y, Hata T et al. Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells. Biochem Biophys Res Commun 2001;282:1110-1113.
77. Kamihira S, Yamada Y, Hirakata Y et al. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: Survivin is an important determinant for prognosis. Br J Haematol 2001;114:63-69.
78. Kawakami H, Tomita M, Matsuda T et al. Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax. Int J Cancer 2005;115:967-974.
79. Sun SC, Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 2005;24:5952-5964.
80. Guzman ML, Neering SJ, Upchurch D et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001;98:2301-2307.
81. Ruland J, Mak TW. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol Rev 2003;193:93-100.
82. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
83. Ariumi Y, Kaida A, Lin JY et al. HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration. Oncogene 2000;19:1491-1499.
84. Van Orden K, Giebler HA, Lemasson I et al. Binding of p53 to the KIX domain of CREB binding protein. A potential link to human T-cell leukemia virus, type I-associated leukemogenesis. J Biol Chem 1999;274:26321-26328.
85. Van Orden K, Yan JP, Ulloa A et al. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene 1999;18:3766-3772.
86. Grant C, Barmak K, Alefantis T et al. Human T cell leukemia virus type I and neurologic disease: Events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol 2002;190:133-159.
87. Jacobson S, Krichavsky M, Flerlage N et al. Immunopathogenesis of HTLV-I associated neurologic disease: Massive latent HTLV-I infection in bone marrow of HAM/TSP patients. Leukemia 1997;11(suppl 3):73-75.
88. Liu M, Yang L, Zhang L et al. HTLV-1 infection leads to arrest in the G1 phase of the cell cycle. J Virol 2008;82:8442-8455.
89. Lee CI, Cowan MJ, Kohn DB et al. Simian immunodeficiency virus infection of hematopoietic stem cells and bone marrow stromal cells. J Acquir Immune Defic Syndr 2004;36:553-561.